These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Bullous dermatitis of the Lyell type of drug etiology]. Severova EI; Frenkel' EN; Cherniak MS Ter Arkh; 1972 Jan; 44(1):81-5. PubMed ID: 5017546 [No Abstract] [Full Text] [Related]
27. [Bullous and necrotic manifestations in barbituric poisoning]. Bureau Y; Barrière H; Litoux P; Bureau B Bull Soc Fr Dermatol Syphiligr; 1971; 78(2):104-8. PubMed ID: 5128239 [No Abstract] [Full Text] [Related]
28. Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis. Paquet P; Ribbens C; Piérard GE Clin Exp Dermatol; 2007 Nov; 32(6):728-32. PubMed ID: 17714530 [TBL] [Abstract][Full Text] [Related]
29. [Immunologic in vitro diagnosis of the Lyell syndrome]. Zucker G; Stiller D Dermatol Monatsschr; 1978 Jul; 164(7):521-5. PubMed ID: 689229 [No Abstract] [Full Text] [Related]
30. [Histological picture report No. 203. Lyell syndrome]. Tritsch H Z Haut Geschlechtskr; 1968 Apr; 43(8):Suppl:63-8. PubMed ID: 5664734 [No Abstract] [Full Text] [Related]
31. [Medicamentous agranulocytosis as a manifestation of drug induced disease]. Gracheva NM Ter Arkh; 1974; 46(1):98-105. PubMed ID: 4454002 [No Abstract] [Full Text] [Related]
32. [Relationship between erythema multiforme exudativum and the Stevens-Johnson and Lyell syndromes]. Neshkov NS; Provizion LN; Kalpakhch'ian PI; Shcherbakov VA Vestn Dermatol Venerol; 1981 Mar; (3):53-5. PubMed ID: 7257598 [No Abstract] [Full Text] [Related]
33. [A case of Lyell's syndrome (toxic epidermal necrolysis)]. Omulecki A; Wranicz A; Mazurek A Pol Tyg Lek; 1965 Jun; 20(25):934-5. PubMed ID: 5844672 [No Abstract] [Full Text] [Related]
34. [Complications of drug therapy]. Lebedeva GV; Kriukova OI; Zelenina OI; Gess LV; Alekseeva IA Vestn Dermatol Venerol; 1983 May; (5):44-7. PubMed ID: 6224363 [No Abstract] [Full Text] [Related]
35. [Prevention of drug therapy complications]. Severova EIa Sov Med; 1982; (1):92-5. PubMed ID: 7063954 [No Abstract] [Full Text] [Related]
38. [Adverse drug reactions in patients at our Debrecen clinic]. Mészáros C Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):11-2. PubMed ID: 5798942 [No Abstract] [Full Text] [Related]
39. In regard to Boccia et al.: assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP) (INT J RADIAT ONCOL BIOL PHYS 2004;60:302-309). Hicsonmez A; Andrieu MN; Akyurek S; Karaca M; Cagar A; Ciner F; Kurtman C Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1279; author reply 1279. PubMed ID: 15752917 [No Abstract] [Full Text] [Related]